tiprankstipranks
Interpace Diagnostics Group (IDXG)
OTHER OTC:IDXG
US Market
IDXG
Interpace Diagnostics Group
RESEARCH TOOLSreports

Interpace Diagnostics Group (IDXG) Ratios

413 Followers

Interpace Diagnostics Group Ratios

IDXG's free cash flow for Q4 2025 was $0.66. For the 2025 fiscal year, IDXG's free cash flow was decreased by $ and operating cash flow was $0.17. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.94 1.94 1.11 0.59 0.85
Quick Ratio
 1.94 1.94 1.00 0.52 0.77
Cash Ratio
 0.49 0.49 0.14 0.20 0.34
Solvency Ratio
 2.21 2.21 0.44 0.06 -0.04
Operating Cash Flow Ratio
 1.52 1.14 0.44 0.22 -0.54
Short-Term Operating Cash Flow Coverage
 0.00 0.00 1.08 0.74 -3.08
Net Current Asset Value
$ -1.57M$ -1.57M$ -5.24M$ -17.84M$ -66.90M
Leverage Ratios
Debt-to-Assets Ratio
 0.02 0.02 0.40 0.86 1.01
Debt-to-Equity Ratio
 0.03 0.03 -2.64 -0.74 -0.26
Debt-to-Capital Ratio
 0.03 0.03 1.61 -2.84 -0.34
Long-Term Debt-to-Capital Ratio
 0.03 0.03 0.00 -0.39 -0.22
Financial Leverage Ratio
 1.51 1.51 -6.67 -0.86 -0.25
Debt Service Coverage Ratio
 154.60 154.60 1.69 0.63 -0.65
Interest Coverage Ratio
 24.31 24.31 12.30 2.78 -3.81
Debt to Market Cap
 0.09 0.14 0.36 2.00 3.10
Interest Debt Per Share
 0.21 0.21 1.49 2.83 4.03
Net Debt to EBITDA
 -0.37 -0.37 0.53 2.01 -4.97
Profitability Margins
Gross Profit Margin
62.31%62.31%63.77%59.44%57.26%
EBIT Margin
10.18%10.18%16.21%6.99%-15.16%
EBITDA Margin
12.30%12.30%17.81%9.54%-7.12%
Operating Profit Margin
10.55%10.55%17.28%6.97%-12.06%
Pretax Profit Margin
9.74%9.74%14.81%2.81%-18.33%
Net Profit Margin
63.46%63.46%14.28%1.99%-18.42%
Continuous Operations Profit Margin
64.51%64.51%14.80%2.77%-18.42%
Net Income Per EBT
651.17%651.17%96.43%71.04%100.50%
EBT Per EBIT
92.41%92.41%85.72%40.26%151.98%
Return on Assets (ROA)
72.63%72.63%45.31%6.16%-36.70%
Return on Equity (ROE)
484.95%109.89%-302.30%-5.30%9.30%
Return on Capital Employed (ROCE)
14.21%14.21%194.11%-62.97%-226.42%
Return on Invested Capital (ROIC)
14.00%14.00%91.56%269.70%-80.44%
Return on Tangible Assets
72.63%72.63%45.31%6.16%-38.79%
Earnings Yield
283.70%451.62%56.58%17.20%-133.07%
Efficiency Ratios
Receivables Turnover
 6.86 6.86 5.49 8.07 6.33
Payables Turnover
 14.85 14.85 10.25 10.56 12.96
Inventory Turnover
 0.00 0.00 14.04 13.29 11.12
Fixed Asset Turnover
 14.67 14.67 15.78 15.15 10.91
Asset Turnover
 1.14 1.14 3.17 3.09 1.99
Working Capital Turnover Ratio
 9.70 13.01 -15.66 -8.67 -11.28
Cash Conversion Cycle
 28.66 28.66 56.84 38.13 62.36
Days of Sales Outstanding
 53.24 53.24 66.46 45.23 57.69
Days of Inventory Outstanding
 0.00 0.00 26.00 27.46 32.83
Days of Payables Outstanding
 24.58 24.58 35.62 34.55 28.17
Operating Cycle
 53.24 53.24 92.46 72.69 90.52
Cash Flow Ratios
Operating Cash Flow Per Share
 1.76 1.32 1.06 0.88 -1.82
Free Cash Flow Per Share
 1.60 1.24 0.86 0.77 -1.89
CapEx Per Share
 0.15 0.08 0.20 0.11 0.08
Free Cash Flow to Operating Cash Flow
 0.91 0.94 0.81 0.88 1.04
Dividend Paid and CapEx Coverage Ratio
 11.53 16.38 5.30 8.06 -23.89
Capital Expenditure Coverage Ratio
 11.53 16.38 5.30 8.06 -23.89
Operating Cash Flow Coverage Ratio
 10.33 7.75 0.79 0.34 -0.48
Operating Cash Flow to Sales Ratio
 0.20 0.15 0.10 0.09 -0.24
Free Cash Flow Yield
81.82%100.62%31.83%71.19%-181.83%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 0.35 0.22 1.77 5.81 -0.75
Price-to-Sales (P/S) Ratio
 0.22 0.14 0.25 0.12 0.14
Price-to-Book (P/B) Ratio
 0.39 0.24 -5.34 -0.31 -0.07
Price-to-Free Cash Flow (P/FCF) Ratio
 1.22 0.99 3.14 1.40 -0.55
Price-to-Operating Cash Flow Ratio
 1.11 0.93 2.55 1.23 -0.57
Price-to-Earnings Growth (PEG) Ratio
 <0.01 <0.01 <0.01 -0.05 0.01
Price-to-Fair Value
 0.39 0.24 -5.34 -0.31 -0.07
Enterprise Value Multiple
 1.45 0.77 1.94 3.22 -6.91
Enterprise Value
 6.92M 3.69M 16.24M 12.36M 15.67M
EV to EBITDA
 1.45 0.77 1.94 3.22 -6.91
EV to Sales
 0.18 0.10 0.35 0.31 0.49
EV to Free Cash Flow
 0.98 0.67 4.31 3.72 -1.96
EV to Operating Cash Flow
 0.89 0.63 3.50 3.26 -2.04
Tangible Book Value Per Share
 5.05 5.05 -0.51 -3.51 -15.09
Shareholders’ Equity Per Share
 5.05 5.05 -0.51 -3.51 -14.88
Tax and Other Ratios
Effective Tax Rate
 -5.62 -5.62 <0.01 0.02 >-0.01
Revenue Per Share
 8.75 8.75 10.70 9.32 7.51
Net Income Per Share
 5.55 5.55 1.53 0.19 -1.38
Tax Burden
 6.51 6.51 0.96 0.71 1.00
Interest Burden
 0.96 0.96 0.91 0.40 1.21
Research & Development to Revenue
 0.02 0.02 0.01 0.02 0.02
SG&A to Revenue
 0.50 0.50 0.45 0.23 0.34
Stock-Based Compensation to Revenue
 <0.01 <0.01 <0.01 0.02 0.04
Income Quality
 0.32 0.24 0.69 4.72 0.35
Currency in USD